Updated review compares diagnosis accuracy of micro-ultrasonography and MRI-targeted biopsy in prostate cancer, indicating potential workflow benefits.
The micro-US-TBx demonstrated csPCa detection and diagnostic accuracy comparable to MRI-TBx. Given its real-time imaging capability, accessibility, and potential workflow advantages, micro-US-TBx may represent a valuable complementary tool within contemporary PCa diagnostic pathways. Further cost-effectiveness studies are warranted to better define its role in clinical practice.
No takes yet. Share an insight, caveat, or question.
Micheleto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: